Vapotherm Inc Logo
US9221073052
A3ESZ4
VAPO

Vapotherm Inc

Loading quotes...

Forecast

The analysts' average price target is €1.44 (-25.77%). The median is €1.44 (-25.77%).

Buy
  2
Hold
  3
Sell
  1

There is currently no news available for this company. We are working on adding more providers to change this.

Financials

In the last year, Vapotherm Inc had revenue of €62.12M and net profit of -€52.64M
(EUR) 2023
YoY
Revenue 62.12M 0.25%
Gross profit 25.58M 59.16%
Net profit -52.64M 50.14%
EBITDA -31.08M 66.79%

Fundamentals

Metric Value
Market capitalization
€12.18M
Number of shares
6.24M
52-week high/low
€3.09 - €0.63
Dividends No
Beta
-1.10
P/E ratio
-0.23
PEG ratio
0.00
P/B ratio
-0.24
P/S ratio
0.20

Company profile

Vapotherm, Inc., a medical technology company, focuses on the development and commercialization of proprietary high velocity therapy products used to treat patients of various ages suffering from respiratory distress in the United States and internationally. The company offers precision flow systems, such as Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic, and Precision Flow Heliox that deliver heated, humidified, and oxygenated air at a high velocity to patients through a small-bore nasal interface. It also provides companion products, including Vapotherm Transfer Unit, which allows patients to be transferred between care areas within the hospital or ambulate while on therapy; Q50 compressor, which provides compressed air necessary to run the precision flow systems; aerosol aeroneb adaptor to facilitate delivery of ultrasonic aerosolized medication; aerosol disposable patient circuit that is designed to streamline the provision of continuous and intermittent delivery of aerosol medication; and tracheostomy adaptors. In addition, Vapotherm, Inc. offers ProSoft cannula to provide gentle contact with the skin; and disposable products comprising single-use disposables and nasal interfaces, as well as Oxygen Assist Modules, which helps clinicians maintain oxygen levels within a target range. The company sells its products to hospitals. Vapotherm, Inc. was founded in 1993 and is headquartered in Exeter, New Hampshire.

Name
Vapotherm Inc
CEO
Joseph F. Army
Headquarters Exeter, nh
USA
Website
Industry
Household Durables
IPO
11/14/2018
Employees 182

Ticker symbols

Exchange Symbol
NYSE
VAPO
Frankfurt
VA20.F
München
VA20.MU
🍪

Parqet  uses cookies. Learn more